发明名称 SALMETEROL XINAFOATE EXHIBITING CONTROLLED PARTICLE SIZE AND PHARMACEUTICAL COMPOSITION
摘要 FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes a new compound - 1-hydroxy-2-naphthalenecarboxylate of 4-hydroxy-<EMI ID=0.386 HE=3 WI=3 TI=CHI>-[[[6-(4-phenylbutoxy)hexyl] amino] methyl]-1,3-benzenedimethanol (salmeterol xinafoate) as easily fluidized crystalline form and exhibiting controlled particle size from 1 to 10 microns and dynamic volume density less 0.1 g x cm that can be used for preparing a pharmaceutical compound with an acceptable carrier. Invention describes also a pharmaceutical composition that can be used for inhalation and containing the above indicated compound. The composition is easy for using and can be fluidized easily. EFFECT: improved quality and properties of the composition. 9 cl, 48 dwg, 6 tbl, 14 ex
申请公布号 RU2136655(C1) 申请公布日期 1999.09.10
申请号 RU19960102011 申请日期 1994.06.30
申请人 GLAKSO GRUP LIMITED 发明人 JORK PITER;KHANNA MEHJZEN
分类号 A61K9/14;A61K9/16;A61K9/72;A61K31/135;A61K31/19;A61P11/00;C07C215/60;C07C217/10;(IPC1-7):C07C215/60 主分类号 A61K9/14
代理机构 代理人
主权项
地址